Atlas Trials

The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.

Clinical trial NCT00346190 · UNKNOWN

Trial details

NCT number
NCT00346190
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Osteoporosis
Start date
2003-01-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.